Veness Adam M 4
4 · Cyteir Therapeutics, Inc. · Filed May 4, 2022
Insider Transaction Report
Form 4
Veness Adam M
General Counsel
Transactions
- Award
Stock Option (Right to buy)
2022-05-02+177,000→ 177,000 totalExercise: $2.35Exp: 2032-04-25→ Common Stock (177,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest as to 25% on April 25, 2023, and 2.083% in 36 monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.